Tag: UGT1A

Seminal vesicle invasion predicts decreased survival in bladder cancer

Updated Outcomes of Sacituzumab Govitecan in Resistant Advanced Urothelial Carcinoma

byDaniel Goldshteinand1 others

February 5, 2024

1. The objective response rate was 28% with a complete response of 5.6% and a partial response of 23%. 2. ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Adalimumab may be associated with improved outcomes in the management of pediatric Crohn’s disease
#VisualAbstract: Daratumumab Reduces Risk of Progression in High-Risk Smoldering Multiple Myeloma
Heated mittens not found to improve physical hand function in patients with osteoarthritis

No Result

View All Result